ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Solvay will sell its Frankfurt-based fluorochemical refrigerants and drug propellants business to Japan’s Daikin Industries for an undisclosed sum. Solvay says the sale of the business, which has $60 million in annual sales, will allow it to focus on more specialized fluorochemicals. For its part, Daikin says the deal will solidify its relationships with European carmakers who are seeking new low-global-warming refrigerants for air-conditioning systems.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X